How the Oncotype DX test could help you make a more informed treatment decision

The results of the Oncotype DX test, combined with other features of the specific cancer, can help you make a more informed decision regarding treatment.

To those eligible, this test can provide new information that will help you decide whether or not to have chemotherapy to treat early-stage, hormone-receptor-positive breast cancer. It can also be helpful in deciding on radiation therapy to treat Ductal Carcinoma in situ.

To learn more about who is eligible for the Oncotype DX test, how Oncotype DX works, and information on other genomic tests, click on the link:

Share This Article

Breast Cancer Ireland

Lower Ground Floor
Breast Cancer Ireland
77 Merrion Square South
Dublin 2

Tel: 00353-1-5160331

Charity No: Chy 19926

Breast Cancer Ireland has been incorporated as Breast Cancer Ireland CLG, trading as: Breast Cancer Ireland